Article

Information about the AGA-ASGE 2013 Clinical Congress of Gastroenterology and Hepatology

News and updates about the upcoming AGA-ASGE 2013 Clinical Congress of Gastroenterology and Hepatology.

AGA-ASGE Clinical Congress of Gastroenterology and Hepatology

January 17-19, 2013

San Diego, CA

Hotel Del Coronado

Visit the conference home page for complete information about the AGA-ASGE 2013 Clinical Congress of Gastroenterology and Hepatology.

Download the conference brochure here.

Hotel and registration information is available here.

Clinical topics and disease states covered at this year’s event will include viral hepatitis, GERD, Crohn’s disease, ulcerative colitis, pancreatitis, cirrhosis, colorectal cancer, biliary strictures, Barrett’s esophagus, celiac disease, eosinophilic esophagitis, gastroparesis, and more.

According to the official conference brochure, clinicians who attend the 2013 AGA-ASGE Clinical Congress of Gastroenterology and Hepatology will be able to:

  • Develop an evidence-based approach to eosinophilic esophagitis, esophageal physiologic studies, dilemmas in PPI use and refractory GERD
  • Identify state-of-the-art management of inflammatory bowel disease
  • Implement recent advances in the management of viral hepatitis, autoimmune hepatitis, cirrhosis and screening of hepatocellular carcinoma
  • Distinguish between the various approaches for managing pancreatic cystic lesions, acute pancreatitis and chronic pancreatitis
  • Apply the latest screening and surveillance practices for average and high-risk CRC
  • Identify the current clinical significance of ongoing research developments of the gastrointestinal microbiome

Highlights of this year’s Congress include:

  • Hands-on courses covering “state of the art expert techniques” in upper (esophagus and gastric therapies) and lower (colonic and intestinal therapies) GI endoscopy
  • Sessions on refractory GERD and new Barrett’s imaging techniques
  • Courses on managing upper GI bleeding, the use of small bowel imaging, and managing celiac disease
  • The Don Powell Lecture: “The Gut Microbiome and Its Potential for Research and Discovery,” delivered by Gail A. Hecht, MD, MS, AGAF
  • Sessions on “demystifying colorectal hereditary syndromes,” dietary and pharmacologic approaches to managing irritable bowel syndrome (IBS), and optimizing ADR
  • Presentations focusing on the assessment and management of patients with irritable bowel disease, including Crohn’s disease and ulcerative colitis
  • Sessions on hepatitis B, hepatitis C, and autoimmune hepatitis
  • Lectures on pancreatic and biliary disorders, including acute pancreatitis, chronic pancreatitis, and pancreatic cystic lesions
  • Breakout sessions covering food allergies, PPI issues, microscopic colitis, biologics and immune modulators, cirrhosis/portal hypertension, and esophageal physiometry testing

Exhibit Hall Hours

Friday, January 18, 2013

12:00pm —1:30pm

2:30pm —5:30pm

Saturday, January 19, 2013

11:00am —11:45am

12:30pm —2:00pm

Related Videos
Ben Samelson-Jones,Ben Samelson-Jones, MD, PhD: Validating Long-Term Safety of Hemophilia AAV Gene Therapy MD, PhD: Validating Long-Term Safety of Hemophilia AAV Gene Therapy
Françoise Bernaudin, MD: A Decade of Follow-up Reveals allo-SCT Superiority Over SOC for Sickle Cell Anemia
Achieving Quick Responses in Sickle Cell Anemia With Early, Appropriate Hydroxyurea Dosing, with Abena Appiah-Kubi, MD, MPH
Steven W. Pipe, MD: Fitusiran With Anti-Thrombin Modulation Yields Effective Bleed Control, Reduces Infusions
Caroline Piatek, MD: Improving Patient-Reported Outcomes in PNH With Danicopan Add-on Therapy
Haydar Frangoul, MD: Preventing VOCs in People With Sickle Cell Disease With Exa-Cel Gene Editing Therapy
Jörn Schattenberg, MD | Credit: Novo Nordisk
Jörn Schattenberg, MD | Credit: Novo Nordisk
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
© 2024 MJH Life Sciences

All rights reserved.